A cluster of cells in the brainstem found to control the body's response to severe blood loss

University of Virginia School of Medicine scientists have discovered a cluster of cells in the brainstem that controls the body's response to severe blood loss, a finding which could benefit efforts to develop new treatments for traumatic injuries.

The discovery pinpoints a collection of neurons that drives a response that maintains blood pressure during blood loss. However, severe blood loss eventually causes cardiovascular collapse – a condition termed "decompensated hemorrhage" marked by an abrupt and dangerous loss of blood pressure – and the new results shed light on why that happens.

During blood loss, the brain coordinates a cardiovascular response that supports blood flow to critical organs, like the heart and brain. Our study shows that the cardiovascular response to blood loss depends on changes in the activity of a few hundred neurons in the brainstem."

George Souza, PhD, Researcher, UVA's Department of Pharmacology

Under pressure

The new results, from UVA's Stephen Abbott, PhD, and collaborators, shed light on an important process the body uses to maintain its blood pressure. The neurons Abbott and his team describe – properly known as "adrenergic C1 neurons" – monitor blood pressure and swing into action during blood loss. When the neurons detect blood loss, they increase nerve activity that constricts blood vessels and maintains proper blood pressure.

The scientists were able to determine this using advanced imaging and a technique called optogenetics that allows for the remote control of neurons using light. Their research revealed that the C1 neurons are hyperactive during blood loss, and this maintains blood pressure. But these neurons become inactive with severe blood loss, resulting in cardiovascular collapse.

Decompensated hemorrhage is the prelude to hemorrhagic shock, in which the body begins to shut down. But the scientists found that re-activating the C1 neurons in lab rats restored both blood pressure and heart rate.

"Our study indicates that reactivating the brain pathways controlling blood pressure during decompensated hemorrhage effectively reverses cardiovascular collapse. We think this indicates that neuromodulation of the pathways described by our study could be a beneficial adjunct therapy for low blood pressure following blood loss," said Abbott, of UVA's Department of Pharmacology.

The scientists note that there may be several factors that contribute to the decline in the activity of the C1 neurons during the onset of decompensated hemorrhage. More research on that front is needed. But the team's findings identify important new directions for that future research.

"These findings illuminate the importance of the brain-body interactions during blood loss and provide a new perspective for the underlying cause of cardiovascular collapse," Abbott said.

Blood loss findings published

The researchers have published their findings in the scientific journal Cell Reports. The research team consisted of George M.P.R. Souza, Ruth L. Stornetta, Daniel S. Stornetta, Patrice G. Guyenet and Stephen B.G. Abbott. All are part of UVA's Department of Pharmacology.

The work was supported by the American Heart Association, grant 19POST34430205, and the National Institutes of Health, grants HL148004, HL28785 and HL074011.

Source:
Journal reference:

Souza, G.M.P.R., et al. (2022) Adrenergic C1 neurons monitor arterial blood pressure and determine the sympathetic response to hemorrhage. Cell Reports. doi.org/10.1016/j.celrep.2022.110480.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Elevated blood glucose levels increase early-onset colorectal cancer risk